Literature DB >> 8033042

Visceral obesity and breast cancer risk.

D V Schapira1, R A Clark, P A Wolff, A R Jarrett, N B Kumar, N M Aziz.   

Abstract

BACKGROUND: The risk for breast cancer and the sex hormone abnormalities noted in breast cancer patients have been demonstrated in women with upper body fat obesity. The objective of this study was to determine if the visceral component of upper body fat obesity was correlated with breast cancer risk.
METHODS: A case-control study of 40 consecutively enrolled women with breast cancer and 40 community-based age, weight, and waist circumference-matched control subjects was conducted. The areas of visceral fat, subcutaneous fat, and total fat were measured using computed tomography at the L-4 vertebral body. Calculations of relative risk for breast cancer were based on these fat compartments.
RESULTS: Patients with breast cancer had a significantly greater visceral fat area (P = 0.01), visceral-to-total-fat area ratio (VT ratio) (P < 0.001) and significantly lower subcutaneous-to-visceral-fat area ratio (SV ratio) (P < 0.001) compared with the matched controls. The relative risk for breast cancer increased with increasing VT ratio (< or = 0.24 = 1.0; > 0.24 = 9.5) (P < 0.0001) and decreasing SV ratio (> or = 3.64 = 1.0; < 3.64 = 8.5) (P = 0.0002).
CONCLUSIONS: Visceral obesity, as assessed by computed tomography, was a significant risk factor for breast cancer in women matched for age, weight, and waist circumference. Comparing the VT ratio for both groups, breast cancer patients had 45% more visceral fat compared with matched control subjects.

Entities:  

Mesh:

Year:  1994        PMID: 8033042     DOI: 10.1002/1097-0142(19940715)74:2<632::aid-cncr2820740215>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  29 in total

Review 1.  Breast cancer hypothesis: a single cause for the majority of cases.

Authors:  R A Wiseman
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

Review 2.  The metabolic syndrome.

Authors:  O Bosello; M Zamboni
Journal:  Eat Weight Disord       Date:  2002-06       Impact factor: 4.652

Review 3.  Obesity as a risk factor for certain types of cancer.

Authors:  K K Carroll
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

Review 4.  The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis.

Authors:  A Shuster; M Patlas; J H Pinthus; M Mourtzakis
Journal:  Br J Radiol       Date:  2011-09-21       Impact factor: 3.039

5.  Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Authors:  Roy Mano; A Ari Hakimi; Emily C Zabor; Marta A Bury; Olivio F Donati; Christoph A Karlo; Wassim M Bazzi; Helena Furberg; Paul Russo
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

6.  A role for FGF2 in visceral adiposity-associated mammary epithelial transformation.

Authors:  Vanessa Benham; Debrup Chakraborty; Blair Bullard; Jamie J Bernard
Journal:  Adipocyte       Date:  2018-03-21       Impact factor: 4.534

7.  Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.

Authors:  Y Zhang; J P Wang; X L Wang; H Tian; T T Gao; L M Tang; F Tian; J W Wang; H J Zheng; L Zhang; X J Gao; G L Li; X Y Wang
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

8.  Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993-2001.

Authors:  Whitney R Robinson; Chiu Kit Tse; Andrew F Olshan; Melissa A Troester
Journal:  Cancer Causes Control       Date:  2014-06-13       Impact factor: 2.506

Review 9.  Energy balance and cancers.

Authors:  M Gerber; D Corpet
Journal:  Eur J Cancer Prev       Date:  1999-04       Impact factor: 2.497

Review 10.  Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.

Authors:  E Warner; R E Heisey; V Goel; J C Carroll; D R McCready
Journal:  Can Fam Physician       Date:  1999-01       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.